VAD for remission induction as a first line and in relapsed adult acute lymphoblastic leukemia (ALL).
Xefteri
E
E
1st Department of Propedeutic Medicine, Laikon Hospital Goudi Athens, Greece.
Polyzos
A
A
Tzianoumis
L
L
Tiniakoy
M
M
Goumakou
H
H
Pagalou
E
E
Kotsis
K
K
Sfikakis
P
P
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction
D005047:Etoposide; D004317:Doxorubicin